(MENAFN) Abraaj Group, the private equity firm, announced that it had sold a 21 percent stake in Integrated Diagnostics Holdings (IDH), a healthcare diagnostics service provider, to Actis, the emerging markets private equity firm, Arabian Business reported.
IDH, which is the result of a merger between Al Mokhtabar and Al Borg Laboratories, offers pathology and molecular diagnostics, genetics testing and basic radiology in Egypt, Sudan and Jordan.
Abraaj, which has about $7.5 billion of assets under management, did not reveal the value of the deal or the size of its remaining stake in IDH.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.